International market

Although the Mobi-Drip will suit the Australian Homecare market, it is primarily targeted at the large export markets of the USA, Europe, Japan and eventually China.

Potential partnerships

Keystone recognises the importance of establishing strong business alliances, a situation that will be a critical component of our strategy to gain International Markets. We therefore welcome enquiries from organisations with an existing market presence in Homecare IV products in the USA and Europe.

Intellectual Property

The IP underpinning the Mobi-Drip concept has been protected by an International Patent. It is envisaged that other Patents will be applied as our product development engineering progresses.

Already, Keystone has engineered a concept for an add on to the disposable Infusion line. This Flow Indicator, if successful, will provide the Mobi-drip device with the only mechanism to visually show the Patient of Nurse that the fluid is actually being infused. When you consider we are working with flow rates of 1, 2 5 & 10ml per hour, this is a very exciting break through and the design involved will almost certainly warrant a Patent.